Mosaic ImmunoEngineering Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Mosaic ImmunoEngineering Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($687.8K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($922.0K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($1.01M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($2.38M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($3.68M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($842.2K) | Jan 26, 2022 |
| FY2021 | May 31, 2020 | ($511) | Jan 26, 2022 |
| FY2020 | May 31, 2019 | ($798.5K) | Aug 24, 2020 |
| FY2019 | May 31, 2018 | ($1.21M) | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($45.4K) | Aug 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($616.1K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($879.7K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($1.40M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($2.63M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($3.50M) | Mar 2, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $183.9K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $435.4K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.05M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.46M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $342.7K | Jan 26, 2022 |
| FY2021 | May 31, 2020 | $0 | Jan 26, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | May 31, 2020 | $996.0K | Aug 24, 2020 |
| FY2020 | May 31, 2019 | $734.1K | Aug 24, 2020 |
| FY2019 | May 31, 2018 | $1.05M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $1.22M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $1.58M | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $1.44M | Aug 29, 2016 |
| FY2015 | May 31, 2014 | $1.66M | Aug 31, 2015 |
| FY2014 | May 31, 2013 | $1.38M | Aug 19, 2014 |
| FY2013 | May 31, 2012 | $1.99M | Aug 23, 2013 |
| FY2012 | May 31, 2011 | $2.55M | Aug 29, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($111.4K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($241.2K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($497.5K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($690.1K) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($679.2K) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($253.0K) | Jan 26, 2022 |
| FY2021 | May 31, 2020 | $500 | Jan 26, 2022 |
| FY2020 | May 31, 2019 | ($760.8K) | Aug 24, 2020 |
| FY2019 | May 31, 2018 | ($880.2K) | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($1.31M) | Aug 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | May 31, 2019 | $0 | Aug 29, 2019 |
| FY2019 | May 31, 2018 | $1.5K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $2.7K | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $0 | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $1.7K | Aug 29, 2016 |
| FY2015 | May 31, 2014 | $0 | Aug 31, 2015 |
| FY2014 | May 31, 2013 | $2.2K | Aug 19, 2014 |
| FY2013 | May 31, 2012 | $2.0K | Aug 23, 2013 |
| FY2012 | May 31, 2011 | $6.8K | Aug 29, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.9K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $141.6K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $179.5K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $261.3K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $269.5K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $457.8K | Jan 26, 2022 |
| FY2020 | May 31, 2020 | $818.6K | Aug 24, 2020 |
| FY2020 | May 31, 2019 | $1.92M | Aug 24, 2020 |
| FY2019 | May 31, 2018 | $2.58M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $3.76M | Aug 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.50M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $6.93M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $6.05M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $5.15M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.07M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $880.3K | Jan 26, 2022 |
| FY2020 | May 31, 2020 | $182.6K | Aug 24, 2020 |
| FY2020 | May 31, 2019 | $228.2K | Aug 24, 2020 |
| FY2019 | May 31, 2018 | $84.8K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $56.6K | Aug 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.48M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($6.79M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($5.87M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | ($4.88M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | ($2.80M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2020 | ($422.5K) | Mar 2, 2023 |
| FY2021 | May 31, 2020 | ($448) | Jan 26, 2022 |
| FY2021 | Mar 31, 2020 | $0 | Jan 26, 2022 |
| FY2020 | May 31, 2019 | $1.70M | Aug 24, 2020 |
| FY2020 | May 31, 2018 | $2.50M | Aug 24, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.53M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($8.84M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($7.92M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($6.91M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($4.53M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($842.8K) | Jan 26, 2022 |
| FY2020 | May 31, 2020 | ($62.19M) | Aug 24, 2020 |
| FY2020 | May 31, 2019 | ($61.13M) | Aug 24, 2020 |
| FY2019 | May 31, 2018 | ($60.33M) | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($59.12M) | Aug 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.6K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $115.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $156.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $220.6K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $226.1K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $352.7K | Jan 26, 2022 |
| FY2020 | May 31, 2020 | $571.9K | Aug 24, 2020 |
| FY2020 | May 31, 2019 | $787.1K | Aug 24, 2020 |
| FY2019 | May 31, 2018 | $2.30M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $979.6K | Aug 29, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Jan 26, 2022 |
| FY2021 | May 31, 2020 | 0 | Jan 26, 2022 |
| FY2020 | May 31, 2019 | 0 | Aug 24, 2020 |
| FY2019 | May 31, 2018 | 0 | Aug 29, 2019 |
| FY2018 | May 31, 2017 | 0 | Aug 29, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Jan 26, 2022 |
| FY2021 | May 31, 2020 | 0 | Jan 26, 2022 |
| FY2020 | May 31, 2019 | 0 | Aug 24, 2020 |
| FY2019 | May 31, 2018 | 0 | Aug 29, 2019 |
| FY2018 | May 31, 2017 | 0 | Aug 29, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.24M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 7.24M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 7.24M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 7.24M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 7.24M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 805,803 | Jan 26, 2022 |
| FY2020 | May 31, 2020 | 401.39M | Aug 24, 2020 |
| FY2020 | May 31, 2019 | 401.39M | Aug 24, 2020 |
| FY2019 | May 31, 2018 | 401.39M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | 401.39M | Aug 29, 2018 |